CEO John Martin's Presentation at the Alliance of Regenerative Medicine (ARM) Investor Day 2015
Sydney, April 14, 2015 AEST (ABN Newswire) - Organised by the Alliance for Regenerative Medicine (ARM), the 3rd Annual Regenerative Medicine Investor Day was held on March 25th 2015 in New York City.
The one-day investor conference focused exclusively on the regenerative medicine and advanced therapies sector. Regeneus Ltd (
ASX:RGS) was one of more than 30 companies that presented during the course of the day.
Below is Regeneus CEO John Martin's presentation to the group, courtesy of the Alliance for Regenerative Medicine (ARM).
To view the video presentation in New York, please visit:
http://www.youtube.com/watch?t=54&v=WGsvzHNEZQA
About Regeneus Ltd
Regeneus Ltd (ASX:RGS) is a Sydney-based clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies. The regenerative therapies seek to address unmet medical needs in human health markets, focusing on neuropathic pain, including osteoarthritis and various skin conditions, with its platform technologies Progenza(TM) and Sygenus. Visit www.regeneus.com.au for more information.
| ||
|
